glp 1 agonists contraindications Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Benefits and Risks of GLP-1

4 GI AEs associated with GIPR modulation Because the food aversive and avoidant effects of GLP-1R agonism appear to be dissociable from satiety, it is theoretically possible to leverage this finding in a next generation, tailored pharmacology

427,428,429 The compound NLY01 is particularly effective at attenuating the activity of proinflammatory microglia and preventing the transformation of astrocytes to a reactive phenotype

Key Takeaways Ozempic, Wegovy, Zepbound, and Mounjaro do not directly cause hair loss, but rapid weight loss and low nutrient intake during treatment can trigger temporary shedding

GLP-1 may affect systemic energy metabolism by regulating adipocyte development, accelerating plasma clearance of glucose and triacylglycerol-derived fatty acids, improving insulin signaling, and stimulating thermogenesis in brown adipose tissue (BAT) [40-45]

In cases of confirmed, severe gastroparesis attributable to GLP-1 therapy, medication discontinuation is generally recommended, consistent with FDA labeling that these agents are not recommended for patients with severe gastroparesis

Most patients notice reduced appetite within the first few days and may lose 3 to 5 pounds in the first week, much of which is water weight